Tuberculosis in Poland: Epidemiological and Molecular Analysis during the COVID-19 Pandemic
- PMID: 36010233
- PMCID: PMC9406582
- DOI: 10.3390/diagnostics12081883
Tuberculosis in Poland: Epidemiological and Molecular Analysis during the COVID-19 Pandemic
Abstract
The COVID-19 pandemic may have a negative impact on the proper implementation of TB control programmes and may increase TB incidence rates in the near future. The aim of this study was to perform an epidemiological and molecular analysis of Mycobacterium tuberculosis strains cultured from tuberculosis patients in Poland in 2020 and to compare the results of monitoring drug-resistant tuberculosis in Poland with previous studies in 2012 and 2016. The analysis was based on questionnaires and strains sent by regional laboratories during the 12 months of 2020. Molecular analysis was performed by spoligotyping 20% of the strains sensitive to the four primary antimycobacterial drugs and all of the drug-resistant strains. The number of strains sent for analysis dropped threefold, from 4136 in 2012 to 1383 in 2020. The incidence of tuberculosis among men was higher than among women. There was an increase in strains' resistance to antimycobacterial drugs in both newly diagnosed patients, from 4.4% in 2012 to 6.1% in 2020, and previously treated patients, from 11.7% to 12.3%. Four-year resistance increased to 1% and 2.1%, respectively. The spoligotype SIT1 was the most abundant among the resistant strains (17%), and SIT53 (13.9%) was the most common among susceptible strains.
Keywords: COVID-19 pandemic; Poland; drug resistance; spoligotyping; tuberculosis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Spoligotype-based comparative population structure analysis of multidrug-resistant and isoniazid-monoresistant Mycobacterium tuberculosis complex clinical isolates in Poland.J Clin Microbiol. 2010 Nov;48(11):3899-909. doi: 10.1128/JCM.00572-10. Epub 2010 Sep 1. J Clin Microbiol. 2010. PMID: 20810763 Free PMC article.
-
[Tuberculosis Laboratory Surveillance Network (TuLSA) study group. The first step for national tuberculosis laboratory surveillance: Ankara, 2011].Mikrobiyol Bul. 2015 Apr;49(2):143-55. doi: 10.5578/mb.9170. Mikrobiyol Bul. 2015. PMID: 26167815 Turkish.
-
Genetic diversity and drug resistance pattern of Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis patients in the Benishangul Gumuz region and its surroundings, Northwest Ethiopia.PLoS One. 2020 Apr 8;15(4):e0231320. doi: 10.1371/journal.pone.0231320. eCollection 2020. PLoS One. 2020. PMID: 32267877 Free PMC article.
-
[Development of antituberculous drugs: current status and future prospects].Kekkaku. 2006 Dec;81(12):753-74. Kekkaku. 2006. PMID: 17240921 Review. Japanese.
-
[Drug resistant tuberculosis].Pol Merkur Lekarski. 2011 May;30(179):362-6. Pol Merkur Lekarski. 2011. PMID: 21675144 Review. Polish.
Cited by
-
Phylogenetic relationships of Mycobacterium tuberculosis isolates in Poland: The emergence of Beijing genotype among multidrug-resistant cases.Front Cell Infect Microbiol. 2023 Mar 16;13:1161905. doi: 10.3389/fcimb.2023.1161905. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37009494 Free PMC article.
References
-
- World Health Organization . Global Tuberculosis Report 2021. World Health Organization; Geneva, Switzerland: 2021.
-
- Korzeniewska-Koseła M., editor. Tuberculosis and Respiratory Tract Diseases in Poland in 2020. Institute of Tuberculosis and Lung Diseases; Warsaw, Poland: 2021.
-
- Zielonka T.M. Epidemiologia gruźlicy w Polsce—Implikacje w praktyce lekarza rodzinnego. Forum Med. Rodz. 2016;1:25–33.
-
- Korzeniewska-Koseła M., editor. Tuberculosis and Respiratory Tract Diseases in Poland in 2019. Institute of Tuberculosis and Lung Diseases; Warsaw, Poland: 2020.
-
- World Health Organization . Global Tuberculosis Report 2017. World Health Organization; Geneva, Switzerland: 2017.
Grants and funding
LinkOut - more resources
Full Text Sources